Amgen's most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $195.00 short put and a strike $185.00 long put offers a potential 20.63% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $195.00 by expiration. The full premium credit of $1.71 would be kept by the premium seller. The risk of $8.29 would be incurred if the stock dropped below the $185.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 67.4 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?
Sun, 20 Jan 2019 13:59:00 +0000
The answer: It's complicated.
See what the IHS Markit Score report has to say about Amgen Inc.
Sat, 19 Jan 2019 13:00:09 +0000
# Amgen Inc
View full report here!
* Perception of the company's creditworthiness is negative
* ETFs holding this stock are seeing positive inflows but are weakening
* Bearish sentiment is low
## Bearish sentiment
Short interest | Positive
Short interest is extremely low for AMGN with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting AMGN.
## Money flow
ETF/Index ownership | Negative
ETF activity is negative and may be weakening. The net inflows of $7.41 billion over the last one-month into ETFs that hold AMGN are among the lowest of the last year and appear to be slowing.
## Economic sentiment
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing.
## Credit worthiness
Credit default swap | Negative
The current level displays a negative indicator. AMGN credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.
Please send all inquiries related to the report to email@example.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Amgen (AMGN) Gains But Lags Market: What You Should Know
Fri, 18 Jan 2019 22:50:10 +0000
Amgen (AMGN) closed at $203.70 in the latest trading session, marking a +0.88% move from the prior day.
Should You Buy Amgen Inc. (NASDAQ:AMGN) For Its Dividend?
Fri, 18 Jan 2019 18:18:24 +0000
Dividends play a key role in compounding returns over time and can form a large part of our portfolio return. Historically, Amgen Inc. (NASDAQ:AMGN) has paid a dividend to shareholders.
FDA Committee Recommends Amgen Drug — But A Key Question Lingers
Thu, 17 Jan 2019 21:06:05 +0000
A Food and Drug Administration committee voted late Wednesday to recommend Amgen's osteoporosis treatment — but to a narrow population. Amgen stock rose Thursday.
Also on Market Tamer…
Follow Us on Facebook